Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia
Recruiting
N/A
Interventional Study
Sarcopenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 60 – 95
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- The Third Affiliated hospital of Zhejiang Chinese Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Introduction: The efficacy of existing therapies for the treatment of sarcopenia is still not satisfactory. Therefore, this randomized controlled, assessor-blinded study was designed to investigate the efficacy and safety of electroacupuncture(EA) therapy in elderly patients with sarcopenia.
Methods and analysis: This randomized controlled trial will enroll 120 elderly patients with sarcopenia. S…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. 60 years ≤ age ≤ 95 years, male or female;
2. Patients are able to walk and communicate independently, and can complete required rehabilitation training;
3. Patients meet the diagnostic criteria proposed by the Asian Working Group for Sarcopenia(AWGS);
4. Patients volunteer t…
Contacts